These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941 [No Abstract] [Full Text] [Related]
3. Alteplase for the management of occluded central venous access devices: safety considerations. Smith LH Clin J Oncol Nurs; 2008 Feb; 12(1):155-7. PubMed ID: 18258586 [No Abstract] [Full Text] [Related]
4. Fibrinolysis and activators of plasminogen. Sobel BE Heart Lung; 1987 Nov; 16(6 Pt 2):775-9. PubMed ID: 3119522 [No Abstract] [Full Text] [Related]
5. Tissue plasminogen activator (t-PA). Will it fulfill its promise? Sherry S N Engl J Med; 1985 Oct; 313(16):1014-7. PubMed ID: 3930959 [No Abstract] [Full Text] [Related]
7. Purple toes syndrome following stroke thrombolysis and warfarin therapy. Mooney T; Joseph P Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530 [No Abstract] [Full Text] [Related]
8. [Anticoagulant drugs. Fibrinolytic drugs]. Cristea E Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1976; 20(2):105-7. PubMed ID: 133400 [No Abstract] [Full Text] [Related]
9. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis. Matosevic B; Knoflach M; Werner P; Pechlaner R; Zangerle A; Ruecker M; Kirchmayr M; Willeit J; Kiechl S Neurology; 2013 Mar; 80(13):1216-24. PubMed ID: 23486872 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tenecteplase in Indian patients with ST-segment elevation myocardial infraction: a future perspetive. Tewari S Indian Heart J; 2008; 60(6):504-6. PubMed ID: 19276486 [No Abstract] [Full Text] [Related]
11. To bleed or not to bleed.. Pena TA Chest; 2010 Dec; 138(6):1520; author reply 1520-1. PubMed ID: 21138890 [No Abstract] [Full Text] [Related]
12. Role of thrombolysis in resuscitation. Ray KK; Chan KH; Sheridan PJ Lancet; 2001 Oct; 358(9290):1372. PubMed ID: 11684258 [No Abstract] [Full Text] [Related]
13. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice. Hoffman JR Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529 [No Abstract] [Full Text] [Related]
14. Intravenous thrombolytic therapy for acute ischemic stroke. Wechsler LR N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326 [No Abstract] [Full Text] [Related]
15. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none. Tangelder MJ; van Hattum ES Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897 [No Abstract] [Full Text] [Related]
16. Antithrombotic agents and invasive procedures--hematologist point of view. Lecompte TP Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666 [TBL] [Abstract][Full Text] [Related]
17. NXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realized? Fisher M Stroke; 2006 Oct; 37(10):2651-2. PubMed ID: 16946143 [No Abstract] [Full Text] [Related]
18. [Future developments in thrombolytic therapy]. Bode C; Runge MS Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201 [TBL] [Abstract][Full Text] [Related]
19. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Liang BA; Lew R; Zivin JA Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160 [TBL] [Abstract][Full Text] [Related]